Shenzhen New Industries Biomedical Engineering Co., Ltd. (SHE:300832)
China flag China · Delayed Price · Currency is CNY
52.05
-0.35 (-0.67%)
Feb 13, 2026, 3:04 PM CST

SHE:300832 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Operating Revenue
4,5414,5273,9203,0402,5392,190
Other Revenue
8.28.29.916.476.175.12
4,5494,5353,9303,0472,5452,195
Revenue Growth (YoY)
2.55%15.42%28.97%19.70%15.97%30.53%
Cost of Revenue
1,3941,2671,064906.2734.3500.87
Gross Profit
3,1553,2692,8662,1411,8111,694
Selling, General & Admin
897.69839.96736.09463.67537.29503.63
Research & Development
498.47453.59366.05317.71215.05150.58
Other Operating Expenses
53.611615.2512.498.575.72
Operating Expenses
1,4761,3361,128807.89753.54671.47
Operating Income
1,6781,9331,7391,3331,0581,023
Interest Expense
-0.54-0.42-0.43-0.27-0.15-
Interest & Investment Income
112.74108.1689.866.7656.659.74
Currency Exchange Gain (Loss)
18.6418.6417.7168.98-31.3-27.1
Other Non Operating Income (Expenses)
2.47-3.37-2.83-2.23-1.432.5
EBT Excluding Unusual Items
1,8122,0561,8431,4661,0811,058
Gain (Loss) on Sale of Investments
29.9328.9418.5515.6218.760.97
Gain (Loss) on Sale of Assets
00.040.050.620.1-0.25
Asset Writedown
-0.43-0.43-1.52-1.52-1.86-0.63
Other Unusual Items
34.699.133.2320.3837.2438.89
Pretax Income
1,8762,0931,8931,5011,1361,097
Income Tax Expense
226.2264.74239.41173.28161.83157.61
Net Income
1,6501,8281,6541,328973.7939.15
Net Income to Common
1,6501,8281,6541,328973.7939.15
Net Income Growth
-10.85%10.57%24.53%36.38%3.68%21.55%
Shares Outstanding (Basic)
786786785785784750
Shares Outstanding (Diluted)
786786786786786750
Shares Change (YoY)
-0.00%-0.01%-0.07%0.04%4.76%6.61%
EPS (Basic)
2.102.332.111.691.241.25
EPS (Diluted)
2.102.332.101.691.241.25
EPS Growth
-10.85%10.59%24.61%36.32%-1.03%14.02%
Free Cash Flow
1,126917.241,096559.17430.28721.84
Free Cash Flow Per Share
1.431.171.400.710.550.96
Dividend Per Share
1.3001.3001.0000.7000.6001.316
Dividend Growth
30.00%30.00%42.86%16.67%-54.40%-
Gross Margin
69.35%72.07%72.93%70.26%71.15%77.18%
Operating Margin
36.90%42.61%44.24%43.74%41.55%46.59%
Profit Margin
36.27%40.31%42.08%43.58%38.25%42.79%
Free Cash Flow Margin
24.75%20.22%27.89%18.35%16.90%32.89%
EBITDA
1,8772,1101,8881,4451,1511,102
EBITDA Margin
41.26%46.52%48.05%47.42%45.23%50.20%
D&A For EBITDA
198.51177.54149.58111.8793.6479.15
EBIT
1,6781,9331,7391,3331,0581,023
EBIT Margin
36.90%42.61%44.24%43.74%41.55%46.59%
Effective Tax Rate
12.06%12.65%12.65%11.54%14.25%14.37%
Revenue as Reported
4,5494,5353,9303,0472,5452,195
Advertising Expenses
-73.7558.5434.3420.252.31
Source: S&P Global Market Intelligence. Standard template. Financial Sources.